FDAFDA · Food and drugs·Recall number D-1449-2016
Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01.
Published August 3, 2016 · Recall initiated: May 18, 2016
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Teva North America
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: 02D163, Exp. 9/2017
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.